Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
Guruprasath P, Kim J, Gunassekaran GR, Chi L, Kim S, Park RW, Kim SH, Baek MC, Bae SM, Kim SY, Kim DK, Park IK, Kim WJ, Lee B.
Guruprasath P, et al. Among authors: kim wj, kim sh, kim s, kim sy, kim dk, kim j.
Biomaterials. 2017 Oct;142:101-111. doi: 10.1016/j.biomaterials.2017.07.024. Epub 2017 Jul 15.
Biomaterials. 2017.
PMID: 28732245